• |
    LogoImage2-AUCD

    AUCD Community Inclusion

    AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

  • |
    LogoImage2-AUCD

    AUCD Maternal and Child Health Engagement

    AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

  • |
    LogoImage2-AUCD

    AUCD Public Health

    AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

  • |
    LogoImage2-AUCD

    AUCD Emerging Leaders Community

    AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.  

Donate

Product

Back to Results

A Phase II Blinded and Placebo-Controlled Study of Nebulized Liposomal Amikacin in the Treatment of CF Patients with P. Aeruiginosa Lung Infe

Center:
AL-UAB PPC
Fiscal Year:
2010
Contact Information:
Product Description:
Abstract and poster presentation during the New Therapies Secion of the North American Cystic Fibrosis Conference in Minneapolis, MN, 2009.
Keyword(s):
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Professionals, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A
Footer-Logo-AUCD

1100 Wayne Avenue, Suite 1000 Silver Spring, MD 20910

Copyright 2024 Association of University Centers on Disabilities

Subscribe to AUCD’s Newsletter

Copyright 2024 Association of University Centers on Disabilities